Niche cancer research Proton Collaborative Group focuses on advancing particle radiotherapy research and connecting leading centers, physicians, and a comprehensive proton therapy registry—an opportunity to offer specialized research analytics, registry management, or clinical trial services to strengthen their collaboration network.

Limited scale With a lean team (2–10 employees) and revenue under $1M, PCG may be seeking scalable solutions that maximize impact with minimal headcount, such as automation, workflow optimization, cloud-based collaboration tools, and managed services.

Strategic leadership Recent leadership change with a new president (Dr. Charles B. Simone) suggests openness to partnerships and strategic initiatives; outreach opportunities could focus on executive-aligned pilots, advisory services, or joint ventures in proton therapy advancement.

Technical footprint Current tech stack includes WordPress, Microsoft 365, and hosting on DigitalOcean, indicating potential needs for cybersecurity hardening, data privacy enhancements, patient data handling improvements, and scalable web and data collaboration platforms.

Market positioning As a research service with proximity to proton therapy centers, PCG could benefit from partnerships or software that supports registry data collection, multicenter study coordination, and access expansion to cutting-edge treatments—a fit for clinical data platforms, registries, and payer/provider alignment tools.